Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM
Devizzi, L., Guidetti, A., Seregni, E., Passera, R., Maccauro, M., Magni, M., Testi, A., Di Nicola, M., Tarella, C., Matteucci, P., Viviani, S., Ruella, M., Carlo-Stella, C., Chiesa, C., Cox, M. C., BVolume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2013.50.2922
Date:
August, 2013
File:
PDF, 92 KB
english, 2013